ATE458201T1 - Methode zur beurteilung von rheumatoider arthritis durch bestimmung von anti-ccp und interleukin 6 - Google Patents

Methode zur beurteilung von rheumatoider arthritis durch bestimmung von anti-ccp und interleukin 6

Info

Publication number
ATE458201T1
ATE458201T1 AT07019998T AT07019998T ATE458201T1 AT E458201 T1 ATE458201 T1 AT E458201T1 AT 07019998 T AT07019998 T AT 07019998T AT 07019998 T AT07019998 T AT 07019998T AT E458201 T1 ATE458201 T1 AT E458201T1
Authority
AT
Austria
Prior art keywords
rheumatoid arthritis
ccp
interleukin
absence
determining anti
Prior art date
Application number
AT07019998T
Other languages
English (en)
Inventor
Norbert Wild
Johann Karl
Veit Peter Grunert
Werner Zolg
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE458201T1 publication Critical patent/ATE458201T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07019998T 2003-12-23 2004-12-21 Methode zur beurteilung von rheumatoider arthritis durch bestimmung von anti-ccp und interleukin 6 ATE458201T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03029658 2003-12-23

Publications (1)

Publication Number Publication Date
ATE458201T1 true ATE458201T1 (de) 2010-03-15

Family

ID=34717197

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07019998T ATE458201T1 (de) 2003-12-23 2004-12-21 Methode zur beurteilung von rheumatoider arthritis durch bestimmung von anti-ccp und interleukin 6

Country Status (13)

Country Link
US (1) US7846674B2 (de)
EP (2) EP1882946B1 (de)
JP (1) JP4495168B2 (de)
AT (1) ATE458201T1 (de)
CA (1) CA2546312C (de)
CY (1) CY1111229T1 (de)
DE (2) DE602004010432T2 (de)
DK (1) DK1882946T3 (de)
ES (2) ES2297521T3 (de)
PL (1) PL1882946T3 (de)
PT (1) PT1882946E (de)
SI (1) SI1882946T1 (de)
WO (1) WO2005064307A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2505921A1 (en) 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
AU2003291484A1 (en) 2002-11-12 2004-06-03 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
ES2288718T3 (es) * 2004-07-07 2008-01-16 F. Hoffmann-La Roche Ag Panel de multiples marcadores para la diabetes de tipo 1 y de tipo 2.
WO2006113529A2 (en) 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
JP2009515141A (ja) * 2005-07-21 2009-04-09 ウェイン ステート ユニバーシティー アスベスト曝露、胸膜中皮腫、および血清オステオポンチンレベル
FI20050814A0 (fi) * 2005-08-11 2005-08-11 Procollagen Oy Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi
US20090142792A1 (en) * 2007-06-21 2009-06-04 Robinson William H Biomarkers for the diagnosis of autoimmune disease
GB0803107D0 (en) 2008-02-20 2008-03-26 Axis Shield Diagnostics Ltd Method
EP2307451B1 (de) 2008-03-21 2016-05-25 Universiteit Hasselt Biomarker für rheumatoide arthritis
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
EP2204655A1 (de) 2008-12-23 2010-07-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Diagnostische Prognose von rheumatoider Arthritis und systemischem Lupus erythematodes
CN101988924B (zh) * 2009-07-31 2014-06-11 上海科新生物技术股份有限公司 检测血液抗环瓜氨酸多肽抗体的试纸条及制备方法
CN102507918B (zh) * 2011-11-09 2014-10-29 四川新健康成生物股份有限公司 抗环瓜氨酸肽抗体测定试剂盒
WO2015009754A2 (en) * 2013-07-15 2015-01-22 Svoboda Steven J Methods and apparatus for assessment of risk for joint injury
JP6220222B2 (ja) 2013-10-28 2017-10-25 シスメックス株式会社 関節リウマチの診断を補助するための方法、システム及びコンピュータプログラム製品
WO2016128348A1 (en) * 2015-02-13 2016-08-18 F. Hoffmann-La Roche Ag Method of assessing rheumatoid arthritis by measuring anti-ccp and anti-pik3cd
CA2985637A1 (en) 2015-05-12 2016-11-17 The General Hospital Corporation Autoantigens for diagnosis of rheumatoid arthritis
WO2017214180A1 (en) 2016-06-07 2017-12-14 The General Hospital Corporation Identification of a t cell epitope of prevotella copri that induces t cell responses in patients with rheumatoid arthritis
CN109929009B (zh) * 2019-03-20 2021-06-04 深圳市新产业生物医学工程股份有限公司 Ccp肽段、包含其的抗原、试剂、试剂盒及应用
US11367521B1 (en) 2020-12-29 2022-06-21 Kpn Innovations, Llc. System and method for generating a mesodermal outline nourishment program

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
SE500044C2 (sv) * 1985-02-15 1994-03-28 Gambro Lundia Ab Peptidförening, antiserum framställt med användning av denna förening samt användning av föreningen
DE69333202T2 (de) 1992-06-26 2004-03-18 The Trustees Of Princeton University Verfahren zur erkennung von krebszellen oder ihren vorstadien mittels p90 und p53-antikörper oder p90 und p53-sonden
US6017693A (en) * 1994-03-14 2000-01-25 University Of Washington Identification of nucleotides, amino acids, or carbohydrates by mass spectrometry
FR2752842B1 (fr) 1996-08-30 1998-11-06 Biomerieux Sa Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide
NL1004539C2 (nl) 1996-11-15 1998-05-20 Stichting Tech Wetenschapp Peptide afgeleid van een door auto-antilichamen van patiënten met reumatoïde artritis herkend antigeen, antilichaam daartegen en werkwijze voor het detecteren van auto-immuunantilichamen.
US6410724B1 (en) * 1997-04-07 2002-06-25 Institut Pasteur Diagnostic means useful for predictive assessment of human hepatocellular carcinoma disease (HCC), as well as diagnostic methods using the same
CZ20001963A3 (cs) * 1997-11-28 2002-04-17 Innogenetics N. V. Peptidy obsahující citrulin rozeznaný sérem revmatické artritidy jako prostředky pro diagnózu a léčbu
FR2773157B1 (fr) 1997-12-30 2001-10-05 Bio Merieux Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
JP4420565B2 (ja) 1998-08-21 2010-02-24 悦郎 尾形 悪性腫瘍の骨転移を判定する方法
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
FR2795735B1 (fr) * 1999-07-01 2001-09-07 Univ Toulouse Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumatoide
WO2001046222A2 (en) 1999-12-21 2001-06-28 Innogenetics N.V. Peptides designed for the diagnosis and treatment of rheumatoid arthritis
WO2001094616A1 (en) 2000-06-02 2001-12-13 Large Scale Proteomics Corp. Protein markers for pharmaceuticals and related toxicity
IL137307A0 (en) 2000-07-13 2001-07-24 Biopreventive Ltd A rapid non-invasive method for differential acute cardiac disease diagnosis
AU2001288921A1 (en) 2000-09-11 2002-03-26 Ciphergen Biosystems, Inc. Human breast cancer biomarkers
US20020072492A1 (en) * 2000-09-12 2002-06-13 Myers Timothy G. Non-genetic based protein disease markers
HN2001000224A (es) * 2000-10-19 2002-06-13 Pfizer Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
AU2002230997A1 (en) 2000-12-15 2002-06-24 Genetics Institute, Llc Methods and compositions for diagnosing and treating rheumatoid arthritis
US6500630B2 (en) * 2001-01-12 2002-12-31 Mayo Foundation For Medical Education And Research Marker for inflammatory conditions
NL1019540C2 (nl) * 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
US20030224386A1 (en) 2001-12-19 2003-12-04 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
US20030175713A1 (en) 2002-02-15 2003-09-18 Clemens Sorg Method for diagnosis of inflammatory diseases using CALGRANULIN C
EP2280285A1 (de) * 2003-09-15 2011-02-02 Oklahoma Medical Research Foundation Verfahren zur Verwendung von Zytokin-Assays zur Diagnose, Behandlung und Beurteilung von Entzündungs- und Autoimmunkrankheiten

Also Published As

Publication number Publication date
CY1111229T1 (el) 2015-06-11
WO2005064307A2 (en) 2005-07-14
PT1882946E (pt) 2010-04-21
JP2007515647A (ja) 2007-06-14
EP1700129A2 (de) 2006-09-13
EP1882946B1 (de) 2010-02-17
DK1882946T3 (da) 2010-05-31
CA2546312C (en) 2010-11-09
SI1882946T1 (sl) 2010-06-30
CA2546312A1 (en) 2005-07-14
US20070264673A1 (en) 2007-11-15
ES2297521T3 (es) 2008-05-01
EP1882946A3 (de) 2008-02-13
EP1700129B1 (de) 2007-11-28
WO2005064307A3 (en) 2005-09-01
DE602004010432D1 (de) 2008-01-10
JP4495168B2 (ja) 2010-06-30
DE602004010432T2 (de) 2008-12-04
US7846674B2 (en) 2010-12-07
PL1882946T3 (pl) 2010-07-30
ES2340328T3 (es) 2010-06-01
EP1882946A2 (de) 2008-01-30
DE602004025636D1 (de) 2010-04-01

Similar Documents

Publication Publication Date Title
CY1111229T1 (el) Μεθοδος προσδιορισμου ρευματοειδους αρθριτιδας με μετρηση αντι-ccp και ιντερλευκλινης 6
ATE521894T1 (de) Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
ATE522812T1 (de) Verfahren und zusammensetzung zum bestimmen von homocystein
DE60213730D1 (de) Echtzeit-Quantifizierung mit internen Standards
EP3640627A3 (de) Verfahren zur verringerung der korrosion in einer installation der ölreffinerie
ATE278805T1 (de) Verfahren zur quantifizierung von cholesterol in lipoproteinen und quantifizierungsreagenzien
DE602005009925D1 (de) Verfahren zur beurteilung rheumatoider arthritis durch messen von anti-ccp und serumamyloid a
ATE541035T1 (de) Modifizierte creatininamid-hydrolase mit verbesserter substrataffinität und reagenszusammensetzung zur bestimmung von creatinin
DE60310012D1 (de) Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
DE60228952D1 (de) Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren
DE60309589D1 (de) Verfahren zum nachweis von arsenionen durch indikatorbakterien
ATE333519T1 (de) Electrochemisches verfahren zum nachweis von nukleinsäuren
ATE414784T1 (de) Blut- und urintest
ATE437372T1 (de) Verfahren zur messung von proinsulin und c-peptid sowie kit dafür
ATE524556T1 (de) Verfahren zur zyklischen nukleotid-bestimmung
FR2858413B1 (fr) Methode analytique d'identification de l'origine naturelle ou fossile de l'acide tartrique par determination du carbone 14-comptage en scintillation liquide
EP1605260A3 (de) Verfahren und Testkit zur Bestimmung des organisch gebundenen Kohlenstoffs (TOC)
ATE339683T1 (de) Verfahren zur detektion und konzentrationsbestimmung von schwefelfreien odoriermitteln in erd- oder brenngas
DE50301307D1 (de) Verwendung von abfangsonden beim nachweis von nukleinsäuren
ATE423310T1 (de) Verfahren und mittel zur bestimmung von gesamtsäure
TW200502399A (en) Recombinant virus and use thereof and method of detecting an analyte in a sample and kit thereof
DK1423708T3 (da) Sammensætninger og fremgangsmåder til bestemmelser af AA4RP
ATE474225T1 (de) Verfahren zur bestimmung von analytenkonzentrationen in einer probe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1882946

Country of ref document: EP